TDAM USA’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
TDAM USA's BIIB Position: Q4 2020 in Review
TDAM USA sold out of Biogen (BIIB) in Q4 2020, closing a stake of 730 shares — an estimated $207K sold.
TDAM USA first reported a position in BIIB in Q2 2016 and held it in 17 quarters. The position peaked at $408K in Q3 2016. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.
- TDAM USA reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
- TDAM USA sold 730 Biogen shares in Q4 2020, an estimated $207K.
- TDAM USA first reported a position in Biogen in Q2 2016 and held it in 17 quarters.
- TDAM USA's Biogen position peaked at $408K in Q3 2016.
- 1,062 funds tracked by Wall St. Rank held Biogen as of Q4 2020.
Based on TDAM USA's 13F filing for Q4 2020, filed 16 Feb 2021.